Determining the cellular architecture of multiple sclerosis lesions
Using in situ sequencing, a collaborative research group analysed 260 genes and discovered new sub-structures in MS lesions.
List view / Grid view
Using in situ sequencing, a collaborative research group analysed 260 genes and discovered new sub-structures in MS lesions.
In this article Drug Target Review's Izzy Wood highlights three of the latest findings using lab automation techniques and technologies that aid scientists.
Swedish researchers unveiled a new cancer protein profile database compiled from artificial intelligence and machine learning.
Researchers at Karolinska Institutet collaborated with other researchers to develop a compound that prevents inflammation by blocking release of TNF alpha...
Antibody mAb806 may be useful in treating aggressive forms of glioblastoma multiform...
A new mechanism for regulating stem cells in the intestine of fruit flies has been discovered by researchers at Stockholm University.
Researchers have identified a new toxin, botulinum neurotoxin type X (BoNT/X), that has the potential to open up a new field of toxin therapeutics...